<p>Administer in a facility equipped to manage possible complications (e.g., anaphylaxis). Administer intravenously (IV) over 1 hr every 3 weeks. PVC equipment is not recommended. Use only a 21 gauge needle to withdraw docetaxel from the vial.</p>

<ul>
	<li><strong>BC locally advanced or metastatic</strong>: 60 mg/m2&nbsp;to 100 mg/m2&nbsp;single agent</li>
	<li><strong>BC adjuvant</strong>: 75 mg/m2&nbsp;administered 1 hour after doxorubicin 50 mg/m2&nbsp;and cyclophosphamide 500 mg/m2&nbsp;every 3 weeks for 6 cycles</li>
	<li><strong>NSCLC</strong>: after platinum therapy failure: 75 mg/m2&nbsp;single agent</li>
	<li><strong>NSCLC</strong>: chemotherapy-naive: 75 mg/m2&nbsp;followed by cisplatin 75 mg/m2&nbsp;</li>
	<li><strong>HRPC</strong>: 75 mg/m2 with 5 mg prednisone twice a day continuously</li>
	<li><strong>GC</strong>: 75 mg/m2&nbsp;followed by cisplatin 75 mg/m2&nbsp;(both on day 1 only) followed by fluorouracil 750 mg/m2&nbsp;per day as a 24-hr IV (days 1-5), starting at end of cisplatin infusion</li>
	<li><strong>SCCHN</strong>: 75 mg/m2&nbsp;followed by cisplatin 75 mg/m2&nbsp;IV (day 1), followed by fluorouracil 750 mg/m2&nbsp;per day as a 24-hr IV (days 1&ndash;5), starting at end of cisplatinin fusion; for 4 cycles</li>
	<li><strong>SCCHN</strong>: 75 mg/m2&nbsp;followed by cisplatin 100 mg/m2&nbsp;IV (day 1), followed by fluorouracil 1000 mg/m2&nbsp;per day as a 24-hr IV (days 1&ndash;4); for 3 cycles</li>
</ul>

<p><br />
For all patients:</p>

<ul>
	<li>Premedicate with oral corticosteroids</li>
	<li>Adjust dose as needed</li>
</ul>